Cong Li
Cong Li
Senior Statistician, Takeda Pharmaceuticals Inc
Verified email at takeda.com
Title
Cited by
Cited by
Year
GPA: a statistical approach to prioritizing GWAS results by integrating pleiotropy and annotation
D Chung, C Yang, C Li, J Gelernter, H Zhao
PLoS Genet 10 (11), e1004787, 2014
1482014
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge
CA Brownstein, AH Beggs, N Homer, B Merriman, WY Timothy, ...
Genome biology 15 (3), 1-18, 2014
842014
Improving genetic risk prediction by leveraging pleiotropy
C Li, C Yang, J Gelernter, H Zhao
Human genetics 133 (5), 639-650, 2014
602014
Inferring functional interaction and transition patterns via dynamic Bayesian variable partition models
J Zhang, X Li, C Li, Z Lian, X Huang, G Zhong, D Zhu, K Li, C Jin, X Hu, ...
Human brain mapping 35 (7), 3314-3331, 2014
402014
On high-dimensional misspecified mixed model analysis in genome-wide association study
J Jiang, C Li, D Paul, C Yang, H Zhao
The Annals of Statistics 44 (5), 2127-2160, 2016
332016
Implications of pleiotropy: challenges and opportunities for mining Big Data in biomedicine
C Yang, C Li, Q Wang, D Chung, H Zhao
Frontiers in genetics 6, 229, 2015
292015
Exploring the genetic architecture of alcohol dependence in African-Americans via analysis of a genomewide set of common variants
C Yang, C Li, HR Kranzler, LA Farrer, H Zhao, J Gelernter
Human genetics 133 (5), 617-624, 2014
212014
Accelerating haplotype-based genome-wide association study using perfect phylogeny and phase-known reference data
Y He, C Li, CI Amos, M Xiong, H Ling, L Jin
PLoS One 6 (7), e22097, 2011
112011
Randomized phase II study of paclitaxel plus alisertib versus paclitaxel plus placebo as second-line therapy for SCLC: primary and correlative biomarker analyses
TK Owonikoko, H Niu, K Nackaerts, T Csoszi, G Ostoros, Z Mark, C Baik, ...
Journal of Thoracic Oncology 15 (2), 274-287, 2020
102020
Testing genetic association with rare and common variants in family data
H Chen, D Malzahn, B Balliu, C Li, JN Bailey
Genetic epidemiology 38 (S1), S37-S43, 2014
92014
Admixture mapping analysis in the context of GWAS with GAW18 data
M Chen, C Yang, C Li, L Hou, X Chen, H Zhao
BMC proceedings 8 (S1), S3, 2014
92014
Detecting hepatitis B viral amino acid sequence mutations in occult hepatitis B infections via Bayesian partition model
Z Lian, QN Tian, Y Liu, V Cento, R Salpini, CF Perno, V Svicher, G Chen, ...
Journal of Proteomics and Bioinformatics 6 (7), 2013
72013
Efficient drug-pathway association analysis via integrative penalized matrix decomposition
C Li, C Yang, G Hather, R Liu, H Zhao
IEEE/ACM transactions on computational biology and bioinformatics 13 (3 …, 2015
62015
High-dimensional genome-wide association study and misspecified mixed model analysis
J Jiang, C Li, D Paul, C Yang, H Zhao
arXiv preprint arXiv:1404.2355, 2014
52014
A penalized multi-trait mixed model for association mapping in pedigree-based GWAS
J Liu, C Yang, X Shi, C Li, J Huang, H Zhao, S Ma
arXiv preprint arXiv:1305.4413, 2013
42013
A penalized linear mixed model for genomic prediction using pedigree structures
C Yang, C Li, M Chen, X Chen, L Hou, H Zhao
BMC proceedings 8 (S1), S67, 2014
22014
Adjustment of familial relatedness in association test for rare variants
C Li, C Yang, M Chen, X Chen, L Hou, H Zhao
BMC proceedings 8 (S1), S39, 2014
12014
The system can't perform the operation now. Try again later.
Articles 1–17